Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of genetic diseases
3.2.1.2 Increasing prevalence of infertility rate
3.2.1.3 Growing advancements in PGT technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of genetic testing
3.2.2.2 Technical challenges in PGT methods
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product & Service, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Products
5.3 Services
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Next generation sequencing (NGS)
6.3 Polymerase chain reaction (PCR)
6.4 Fluorescent in-situ hybridization (FISH)
6.5 Array
6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Aneuploidy screening
7.3 Structural chromosomal rearrangement
7.4 Monogenic/single-gene disorder screening
7.5 Human leukocyte antigen (HLA) typing
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals & clinics
8.3 Diagnostic laboratories
8.4 Fertility centers
8.5 Research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Agilent Technologies
10.2 Fulgent Genetics
10.3 Genea BIOMEDX
10.4 Illumina
10.5 Medicover Genetics
10.6 Natera
10.7 Revvity
10.8 RGI
10.9 Takara Bio
10.10 Thermo Fisher Scientific
10.11 Varinos
10.12 Virtus Health
10.13 Vitrolife Group (Igenomix)
